Transcription Factor 21 Regulates Estrogen Receptor-Beta and Steroidogenic Factor-1 Expression Via Upstream Stimulatory Factor-2 in Endometriosis.

Q. Xue,P. Wu,Y. Zhou,C. Zeng,X. Li,Z. Dong
DOI: https://doi.org/10.1016/j.fertnstert.2017.07.289
IF: 6.7
2017-01-01
Fertility and Sterility
Abstract:To investigate the molecular mechanisms by which transcription factor 21 (TCF21) regulates Estrogen receptor-beta (ERβ, encoded by ESR2 gene) and steroidogenic factor-1 (SF-1, encoded by NR5A1 gene) expression in endometriosis. And demonstrate the effect of TCF21 on cell proliferation and invasion of endometriotic stromal cells. In vitro experimental study with the use of human endometriotic stromal cells (ESCs) and endometrial cells (EMs). ESCs and EMs derived from ovarian endometriomas and eutopic endometrial tissues; mRNA and protein expression were measured by real-time PCR and Western blot, respectively; The activity of gene promoter was determined by luciferase assay; ESCs were transfected with siRNA and plasmids; Binding of TCF21 and Upstream Stimulatory Factor-2 (USF2) to the ERβ and SF-1 promoters were measured by chromatin immunoprecipitation; Protein-protein association was assessed by coimmunoprecipitation assay; Cell proliferation and invasion were assessed by CCK-8 assay and in vitro transwell assay. Levels of TCF21 mRNA in ESCs were much higher (1455-fold) than those in EMs. The expression of ERβ and SF-1 were down-regulated (38% and 14%, respectively) by TCF21 knockdown, while were up-regulated (3.7-fold and 1.7-fold, respectively) by TCF21 overexpression in ESCs. Site-mutation of the E-box sequence (located at -99∼-94) of ERβ promoter dramatically ablated its luciferase activity by 83%, whereas the critical importance of E-box sequence for SF-1 promoter activity has been revealed. The binding activities of USF2, but not TCF21, to the ERβ and SF-1 promoters were higher in ESCs than EMs. TCF21 and USF2 functioned as a transcription complex. TCF21 knockdown significantly decreased the binding activities of USF2 to ERβ and SF-1 promoters via disrupting the TCF21-USF2 complex. Meanwhile, TCF21 knockdown decreased MMP9, cyclinD1 expression and inhibited proliferation and invasion of ESCs, as TCF21 overexpression exhibited the opposite results. The elevated levels of TCF21 in endometriosis enhanced ERβ and SF-1expression via forming heterodimers with USF2, which bound to the E-box sequence of ERβ and SF-1 promoters. Meanwhile, TCF21 induced proliferation and invasion of ESCs. These findings indicate that TCF21 may be a potential target for treating endometriosis.
What problem does this paper attempt to address?